Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)

PHASE2

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Study was stopped after careful review of product manufacturing needs and available resources. Decision reflects consideration of feasibility, enrollment challenges, and overall program goals.

Conditions

Hyperactivity in Children With Down Syndrome
Impulsivity in Children With Down Syndrome

Interventions

DRUG: Guanfacine Hydrochloride Immediate Release
DRUG: Placebo

Sponsor

Rachel G. Greenberg, MD, MB, MHS

Collaborators

[object Object]
[object Object]